Medical Updates on Bioabsorbable Stent Market to Grow at 11.5% CAGR, Led by Coronary and Peripheral Artery Diseases
The report provides an overview of the global bioresorbable stents market. It aims at estimating the market size and future growth potential of this market across different segments such as material, absorption rate, application, end users, and region.
(EMAILWIRE.COM, October 10, 2018 ) Bioresorbable stents market is segmented into coronary artery diseases and peripheral artery diseases. In 2017, coronary artery diseases are expected to grow at the highest CAGR during the forecast period. This positive growth is attributed to factors such as rising aging population prone to coronary artery diseases and the adoption of unhealthy lifestyle habits leading to increased risk of these diseases.
Get Free Market Updates Now at http://www.reportsnreports.com/contacts/requestsample.aspx?name=597649 .
The global bioresorbable stents market expected to reach USD 417.2 million by 2022 from USD 223.6 million in 2016, at a CAGR of 11.5% during forecast period. Growing aging population susceptible to coronary and peripheral artery diseases, rising PCI procedures, increasing focus of companies on clinical trials of bioresorbable stents, increasing adoption of these stents by physicians and patients, and patients preference for minimally invasive therapies are factors that are expected to drive market growth in future.
Study estimates global bioresorbable stents market size for 2017 and projects its demand till 2022. In primary research process, various sources from both demand side and supply side were interviewed to obtain qualitative and quantitative information of report. Primary sources from demand side include various industry CEOs, vice presidents, marketing directors, technology and innovation directors, and related key executives from various players in global bioresorbable stents market.
Target Audience for this Report:
Bioabsorbable stent manufacturing companies
Pharmaceutical manufacturing companies
Healthcare institutions (hospitals and clinics)
Stent distributors and suppliers
Research institutes
Venture capitalists
Health insurance payers
Market research and consulting firms
Get Discount on https://www.reportsnreports.com/contacts/discount.aspx?name=597649 .
Global bioresorbable stents market into material, absorption rate, applications, end users, and region. On basis of materials, global bioresorbable stents market segmented into bioresorbable polymer-based stents & bioresorbable metallic stents. Bioresorbable polymer-based segment expected to dominate market in 2017.
The global bioresorbable stents market is niche with the presence of a limited number of players. Prominent players in the bioresorbable stents market include Abbott Laboratories (U.S.), BIOTRONIK SE & Co. KG (Germany), REVA Medical, Inc. (U.S.), Elixir Medical Corporation (U.S.), and Kyoto Medical Planning Co., Ltd. (Japan).
Click Here for Complete Information on https://www.reportsnreports.com/contacts/inquirybeforebuy.aspx?name=597649 .
Research coverage:
The report also will help the stakeholders understand the pulse of the market and provide them with information regarding key market drivers, restraints challenges, and opportunities. The report will help the market leaders/new entrants in this market by providing them with the closest approximations of the revenue numbers for the overall global bioresorbable stents market and its subsegments.
Key benefits of buying the report:
Report will help market leaders/new entrants in this market by providing them with closest approximations of revenue numbers for overall bioresorbable stents market & its subsegments. This report will help stakeholders to understand competitive landscape better & gain insights to position their businesses better & focus on suitable go-to-market strategies. Report also will help stakeholders understand pulse of market & provide them with information regarding key market drivers, restraints challenges, & opportunities.
Get Free Market Updates Now at http://www.reportsnreports.com/contacts/requestsample.aspx?name=597649 .
The global bioresorbable stents market expected to reach USD 417.2 million by 2022 from USD 223.6 million in 2016, at a CAGR of 11.5% during forecast period. Growing aging population susceptible to coronary and peripheral artery diseases, rising PCI procedures, increasing focus of companies on clinical trials of bioresorbable stents, increasing adoption of these stents by physicians and patients, and patients preference for minimally invasive therapies are factors that are expected to drive market growth in future.
Study estimates global bioresorbable stents market size for 2017 and projects its demand till 2022. In primary research process, various sources from both demand side and supply side were interviewed to obtain qualitative and quantitative information of report. Primary sources from demand side include various industry CEOs, vice presidents, marketing directors, technology and innovation directors, and related key executives from various players in global bioresorbable stents market.
Target Audience for this Report:
Bioabsorbable stent manufacturing companies
Pharmaceutical manufacturing companies
Healthcare institutions (hospitals and clinics)
Stent distributors and suppliers
Research institutes
Venture capitalists
Health insurance payers
Market research and consulting firms
Get Discount on https://www.reportsnreports.com/contacts/discount.aspx?name=597649 .
Global bioresorbable stents market into material, absorption rate, applications, end users, and region. On basis of materials, global bioresorbable stents market segmented into bioresorbable polymer-based stents & bioresorbable metallic stents. Bioresorbable polymer-based segment expected to dominate market in 2017.
The global bioresorbable stents market is niche with the presence of a limited number of players. Prominent players in the bioresorbable stents market include Abbott Laboratories (U.S.), BIOTRONIK SE & Co. KG (Germany), REVA Medical, Inc. (U.S.), Elixir Medical Corporation (U.S.), and Kyoto Medical Planning Co., Ltd. (Japan).
Click Here for Complete Information on https://www.reportsnreports.com/contacts/inquirybeforebuy.aspx?name=597649 .
Research coverage:
The report also will help the stakeholders understand the pulse of the market and provide them with information regarding key market drivers, restraints challenges, and opportunities. The report will help the market leaders/new entrants in this market by providing them with the closest approximations of the revenue numbers for the overall global bioresorbable stents market and its subsegments.
Key benefits of buying the report:
Report will help market leaders/new entrants in this market by providing them with closest approximations of revenue numbers for overall bioresorbable stents market & its subsegments. This report will help stakeholders to understand competitive landscape better & gain insights to position their businesses better & focus on suitable go-to-market strategies. Report also will help stakeholders understand pulse of market & provide them with information regarding key market drivers, restraints challenges, & opportunities.
Contact Information:
ReportsnReports
Mr. Hrishikesh
Tel: + 18883915441
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results
ReportsnReports
Mr. Hrishikesh
Tel: + 18883915441
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results